Abstract:The long-term mortality and morbidity of patients with severe fever with thrombocytopenia syndrome (SFTS) remain unclear. This retrospective cohort study was conducted using the National Health Insurance Service dataset on hospitalized patients with SFTS aged ≥20 years between 2016 and 2021 (n = 1,217). Each SFTS case was matched with three controls hospitalized for non-SFTS-related diseases using propensity score matching. The all-cause mortality of patients with SFTS was evaluated during the one-year follow-up and compared with that of controls. Post-discharge events were investigated to determine the effects of SFTS on post-acute sequelae. Finally, 1,105 patients with SFTS and 3,315 controls were included. Patients with SFTS had a higher risk of death during the one-year follow-up than that of controls (hazard ratio [HR], 2·26; 95% confidence interval [CI], 1·82–2·81). Thirty-day mortality was significantly higher in the SFTS group (HR, 3·99; 95% CI, 3·07–5·19) than in the control group. An increased risk of death after 31–365 days was observed among controls, though this difference was significant only among patients in their 80s (HR, 0·18; 95% CI, 0·06–0·57). For post-discharge events, patients in the SFTS group exhibited a higher risk of readmission (HR, 1·17; 95% CI, 1·04–1·32) and emergency room visit (HR, 2·32; 95% CI, 1·96–2·76) than those in the control group. SFTS induces a higher risk of short-term mortality and post-acute sequelae in hospitalized patients during a one-year follow-up than non-SFTS-related diseases. Our results provide guidance for the management of SFTS. Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening viral disease, which has expanded beyond Asian countries. However, most studies have focused on the short-term mortality of patients with SFTS, and knowledge of their long-term outcomes is limited. This nationwide cohort study evaluated long-term outcomes of hospitalized patients with SFTS between 2016 and 2021 using the national dataset. We found that hospitalized patients with SFTS had higher one-year mortality (HR, 2.26) than those without SFTS. An increased mortality risk was attributed to death in the first 30 days of hospitalisation (HR, 3.99). Although the long-term mortality (31–365 days) did not differ between patients with and without SFTS, except for those in their 80s, patients with SFTS suffered from post-acute events, including readmission (HR, 1.17) or emergency room visit (HR, 2.32) during the one-year follow-up. SFTS is an emerging infectious disease that demands attention. The disease burden extends beyond the acute phase, with patients often experiencing ongoing health problems even after hospital discharge. Our findings underscore the post-acute burden of SFTS and offer valuable insights for the development of effective management plans for acute and post-acute illnesses in patients with SFTS.

Clinical features and epidemiology of severe fever with thrombocytopenia syndrome in dogs in the Republic of Korea: an observational study (2019–2020)

Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs

Severe Fever with Thrombocytopenia Syndrome in South Korea, 2016-2021: Clinical Features of Severe Progression and Complications

Clinical factors associated with SFTS diagnosis and severity in cats

Effect of Severe Fever With Thrombocytopenia Syndrome Virus Genotype on Disease Severity, Viral Load, and Cytokines in South Korea

Elucidation of prognostic factors in the acute phase of feline severe fever with thrombocytopenia syndrome virus infection

Outbreaks of nosocomial feline calicivirus-associated virulent systemic disease in Korea

Clinical and Pathological Findings in Fatal Cases of Severe Fever With Thrombocytopenia Syndrome With High Viremia in Cats

Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy

One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: A nationwide cohort study in South Korea

Clinical and Epidemiological Study on Severe Fever with Thrombocytopenia Syndrome in Yiyuan County, Shandong Province, China

Analysis of Changes in Viral Load and Inflammatory Cytokines, as Well as the Occurrence of Secondary Infections, in SFTS Patients Treated with Specific Treatments: A Prospective Multicenter Cohort Study

Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea

Analysis of Severe Fever with Thrombocytopenia Syndrome in Critical Ill Patients in Central China.

Factors and outcomes in Severe Fever with Thrombocytopenia Syndrome (SFTS): A systematic review

Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes

A Model for the Production of Regulatory Grade Viral Hemorrhagic Fever Exposure Stocks: from Field Surveillance to Advanced Characterization of SFTSV

Serological investigation of seven zoonotic pathogens in companion dogs in South Korea, 2018-2021

Prevalence of severe fever with thrombocytopenia syndrome virus in animals in Henan Province, China

Whole-genome sequencing and genetic diversity of severe fever with thrombocytopenia syndrome virus using multiplex PCR-based nanopore sequencing, Republic of Korea